Management of high risk T1 gastric adenocarcinoma following endoscopic resection

Best Pract Res Clin Gastroenterol. 2024 Feb:68:101887. doi: 10.1016/j.bpg.2024.101887. Epub 2024 Jan 30.

Abstract

Endoscopic submucosal dissection has revolutionized the treatment of early gastric cancer. However, cases that do not meet the curability criteria have a higher risk of lymph node metastasis and salvage surgery is still considered the next treatment approach to increase the chance of cure. Nevertheless, not all high-risk resections entail the same level of risk, emphasizing the utmost importance of individualized stratification for further treatment. In this review, we aim to examine the current evidence concerning the management following a high-risk non-curative resection, highlighting the existing approaches, while also presenting upcoming strategies that attempt to improve patient outcomes, minimize adverse events, and provide a tailored management.

Keywords: Early gastric cancer; Endoscopic submucosal dissection; High-risk resection.

Publication types

  • Review

MeSH terms

  • Adenocarcinoma* / pathology
  • Adenocarcinoma* / surgery
  • Endoscopic Mucosal Resection* / adverse effects
  • Endoscopy
  • Gastric Mucosa / pathology
  • Gastric Mucosa / surgery
  • Humans
  • Retrospective Studies
  • Stomach Neoplasms* / pathology
  • Stomach Neoplasms* / surgery
  • Treatment Outcome